Who has invested in SyMap Medical?

Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China are named among the investors backing SyMap Medical.

SyMap Medical Funding: $115M Raised, Series E (2021)

SyMap Medical funding overview

SyMap Medical is based in Suzhou, China. SyMap Medical has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in December 2021. The round record for SyMap Medical runs through 2021; nothing later has been disclosed. Investors on record include Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China. 4 distinct backers are named across the disclosed rounds.

SyMap Medical at a glance

Total raised: $115M
Latest round: Series E
Latest round date: December 2021
Headquarters: Suzhou, China
Notable investors: Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China

Frequently asked about SyMap Medical funding

How much has SyMap Medical raised?: SyMap Medical has raised $115M in total disclosed funding across the rounds on record.
Who has invested in SyMap Medical?: Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China are named among the investors backing SyMap Medical.
What was the latest SyMap Medical funding round?: The most recent disclosed round is a Series E, announced in December 2021.
Where is SyMap Medical based?: SyMap Medical is based in Suzhou, China.
When did SyMap Medical last raise?: The last disclosed SyMap Medical round closed in December 2021 at Series E.

SyMap Medical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.

SyMap Medical Funding: $115M Raised, Series E (2021)

SyMap Medical funding overview

SyMap Medical at a glance

Frequently asked about SyMap Medical funding

Companies related to SyMap Medical (22)

Browse related funding lists (4)